SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Gilda Radner — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientGilda Radner
Date of birth1946-06-28
IdentifiersMRN HR-ML026-SYN-TD; SSN (made up) 000-26-8821
Document date1986-04-14
AuthorDelia Marchand, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Biopsy result and gynecologic oncology consultation. [S]

History of Present Illness

Ms. Radner returns eight days after her first visit. The transvaginal ultrasound the next day showed solid and cystic masses in both ovaries with ascites; CT of the chest, abdomen and pelvis the day after that showed omental and peritoneal disease without spread to the liver, lungs or lymph nodes; and an ultrasound-guided core biopsy of the omentum two days later shows high-grade serous carcinoma of Mullerian origin. Dr. Varghese of gynecologic oncology saw her this morning. The bloating and early fullness are the same; she is eating small meals and has had no vomiting, and her bowels move every day. She says she is frightened but relieved to have an answer within a week. She had genetic counseling this afternoon. She has had no thoughts of self-harm. [S]

ElementDetail
DiagnosisHigh-grade serous carcinoma of both ovaries with omental and peritoneal spread; clinical FIGO stage IIIC
ImagingUltrasound: bilateral complex masses, ascites. CT: omental caking, a right diaphragm nodule, no liver, lung or nodal disease
SymptomsBloating and early fullness unchanged; no vomiting or bowel obstruction
CoordinationGynecologic oncology seen today; surgery planned in one week; genetic counseling done
Her questionsWhether surgery can remove it all, and what the genetic test means for her family

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; no fever or night sweats; weight steady
RespiratoryNegativeNo cough or breathlessness
GastrointestinalPositiveBloating and early fullness; no vomiting; bowels open daily
GenitourinaryPositivePassing urine more often; no bleeding
CardiovascularNegativeNo leg swelling or calf pain
PsychiatricPositiveFrightened and tearful at times; PHQ-9 7 and GAD-7 8; no thoughts of self-harm

6 systems reviewed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1986-04-14Body height160cmS
1986-04-14Body weight58.9kgS
1986-04-14Body mass index (BMI) [Ratio]23kg/m2S
1986-04-14Systolic blood pressure122mm[Hg]S
1986-04-14Diastolic blood pressure78mm[Hg]S
1986-04-14Heart rate96/minS
1986-04-14Respiratory rate16/minS
1986-04-14Body temperature36.8CelS
1986-04-14Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1986-04-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
1986-04-14Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]8{score}S

Physical Exam

Vital signs recorded on 1986-04-14; see the Vital Signs section. [S]

SystemFinding
GeneralTired but composed; weight 58.9 kg; blood pressure 122/78, pulse 96
AbdomenDistended with shifting dullness; firm fullness in the upper abdomen consistent with the omental disease; non-tender; biopsy site clean
PelvicExamined with Dr. Varghese: fixed, irregular masses in both adnexa, larger on the right; cervix normal; no nodularity of the rectovaginal septum
Lymph nodesNo supraclavicular, axillary or inguinal nodes
ExtremitiesNo leg swelling
PsychiatricAnxious, tearful briefly, organized; humor intact

Problems

ProblemClinical statusVerificationCodeProvenance
Persistent bloating with tightness of her clothes, feeling full after a few bites, a dull lower abdominal and pelvic ache, and passing urine more often, on most days for about four weeks, in a woman of 39: the ovarian cancer symptom index is positive. Examination: a distended abdomen with shifting dullness and a firm, fixed, irregular mass in the right adnexa. Suspected ovarian cancer; transvaginal ultrasound, CT, CA-125 and gynecologic oncology review booked within the weekresolvedconfirmed R19.00S — Synthetic presenting problem linked to her documented abdominal symptoms; superseded by the diagnosis at the gynecologic oncology consultation.
High-grade serous carcinoma of both ovaries (Mullerian origin), diagnosed by image-guided omental core biopsy (PAX8 and WT1 positive, p53 aberrant), with bilateral adnexal masses, ascites, omental and diaphragmatic disease on CT: clinical FIGO stage IIIC; synthetic modern detail linked to her documented ovarian canceractiveconfirmed C56.3S — Synthetic histology and stage; the documented diagnosis was stage IV ovarian cancer (D).
Peritoneal and omental metastases of the ovarian cancer, with ascitesactiveconfirmed C78.6S — Synthetic extent of disease on CT and biopsy.
Family history of ovarian cancer in three relatives (her grandmother, an aunt, and a cousin) in a woman of Ashkenazi Jewish ancestry; no genetic testing in the family is knownactiveconfirmed Z80.41S — Synthetic coding of her documented family history; the basis for genetic counseling.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyOvarian cancer symptom indexAt presentationUp to datePositive at the first visit: bloating, early fullness and pelvic pain on most days for about four weeks
ImagingTransvaginal ultrasoundAt presentation with a pelvic massUp to dateDone the day after the first visit: bilateral solid and cystic adnexal masses with blood flow and ascites (O-RADS 5)
ImagingCT of the chest, abdomen and pelvis with contrastBefore primary treatmentUp to dateOmental caking, a 1.2 cm right diaphragm nodule and pelvic peritoneal nodules; no liver, lung or lymph node disease; no pleural effusion
LaboratoryTissue diagnosisBefore treatment, by biopsy or at surgeryUp to dateOmental core biopsy: high-grade serous carcinoma, PAX8 and WT1 positive, p53 aberrant
LaboratoryCA-125 and CEAAt diagnosisUp to dateCA-125 1240 U/mL and CEA 1.6 ng/mL at the first visit; the ratio points to an ovarian rather than a bowel primary
LaboratoryBlood count, kidney and liver function before surgeryWithin 30 days before surgeryUp to dateFrom the first visit: hemoglobin 12.4 g/dL, platelets 412, creatinine 0.72 mg/dL, albumin 3.6 g/dL
LaboratoryHepatitis B, hepatitis C and HIV screeningBefore chemotherapyOrderedHepatitis B surface antigen, core antibody and surface antibody, hepatitis C antibody, and HIV drawn today
ReferralGenetic counselingAt diagnosis of epithelial ovarian cancerCompleted todayPedigree taken and consent given
LaboratoryGermline multigene panelOnce, at diagnosis, for every woman with epithelial ovarian cancerOrderedBRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 and the Lynch syndrome genes; result in about three weeks
LaboratoryTumor testing for BRCA1 and BRCA2 and homologous recombination deficiencyOn the surgical specimen, before the maintenance decisionDueTo be sent from the operation next week
ReferralGynecologic oncologyBefore any surgery for suspected ovarian cancerCompleted todaySeen this morning; recommendations in the consultation note
Medication safetyThromboprophylaxis after cancer surgeryFrom surgery for four weeksDueEnoxaparin 40 mg daily for 28 days planned after the operation
SurveyDistress and depression screen (PHQ-9)At diagnosis, at each treatment phase, and when symptoms changeCompleted todayPHQ-9 7 and GAD-7 8, mild, with fear about the diagnosis; no thoughts of self-harm
Self-managementPsychosocial support and informationAt diagnosis and throughoutCompleted todayPlain explanation of the diagnosis and plan with written information; she chose who would be told; details of a cancer support community group given

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 4.2026 (2026); Konstantinopoulos PA, et al. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline. J Clin Oncol 2020;38(11):1222-1245 (2020); Goff BA, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007;109(2):221-227 (2007); Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk (2017); Key NS, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update. J Clin Oncol 2023;41(16):3063-3071 (2023); Hwang JP, et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol 2020 (2020); Depression and Suicide Risk in Adults: Screening (2023)

Follow-up: Surgery in one week with Dr. Varghese. Primary care review three weeks after surgery, on the first chemotherapy day, with the pathology and genetic results. Call for vomiting, inability to eat, breathlessness, or leg swelling. Next scheduled visit 1986-05-12: review three weeks after cytoreductive surgery: pathology, genetic results, and the first cycle of chemotherapy. [S]